DE68929112T2 - Nachweis von Yersinia Intermedia - Google Patents
Nachweis von Yersinia IntermediaInfo
- Publication number
- DE68929112T2 DE68929112T2 DE68929112T DE68929112T DE68929112T2 DE 68929112 T2 DE68929112 T2 DE 68929112T2 DE 68929112 T DE68929112 T DE 68929112T DE 68929112 T DE68929112 T DE 68929112T DE 68929112 T2 DE68929112 T2 DE 68929112T2
- Authority
- DE
- Germany
- Prior art keywords
- probe
- yersinia
- probes
- rrna
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000607481 Yersinia intermedia Species 0.000 title claims abstract description 20
- 239000000523 sample Substances 0.000 claims abstract description 152
- 241000607447 Yersinia enterocolitica Species 0.000 claims abstract description 58
- 229940098232 yersinia enterocolitica Drugs 0.000 claims abstract description 50
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims abstract description 13
- 239000002853 nucleic acid probe Substances 0.000 claims abstract description 13
- 238000009396 hybridization Methods 0.000 claims description 39
- 238000012360 testing method Methods 0.000 claims description 26
- 150000007523 nucleic acids Chemical class 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 16
- 108020004707 nucleic acids Proteins 0.000 claims description 14
- 102000039446 nucleic acids Human genes 0.000 claims description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 12
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 12
- 230000000295 complement effect Effects 0.000 abstract description 3
- 239000012634 fragment Substances 0.000 abstract 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 21
- 108091028043 Nucleic acid sequence Proteins 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 8
- 230000007717 exclusion Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000003705 ribosome Anatomy 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 3
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000007899 nucleic acid hybridization Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 108020004418 ribosomal RNA Proteins 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 241000588771 Morganella <proteobacterium> Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- OAICVXFJPJFONN-OUBTZVSYSA-N Phosphorus-32 Chemical compound [32P] OAICVXFJPJFONN-OUBTZVSYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010048249 Yersinia infections Diseases 0.000 description 1
- 241001135251 Yersinia kristensenii Species 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008863 intramolecular interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- -1 nucleic acid hydride Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229940097886 phosphorus 32 Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16964688A | 1988-03-18 | 1988-03-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE68929112D1 DE68929112D1 (de) | 2000-01-13 |
| DE68929112T2 true DE68929112T2 (de) | 2000-09-28 |
Family
ID=22616562
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE68929112T Expired - Fee Related DE68929112T2 (de) | 1988-03-18 | 1989-03-17 | Nachweis von Yersinia Intermedia |
| DE68925435T Expired - Fee Related DE68925435T2 (de) | 1988-03-18 | 1989-03-17 | Nachweis von Yersinia enterocolitica durch Verwendung von Nucleinsäuresonden |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE68925435T Expired - Fee Related DE68925435T2 (de) | 1988-03-18 | 1989-03-17 | Nachweis von Yersinia enterocolitica durch Verwendung von Nucleinsäuresonden |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP0339783B1 (enExample) |
| JP (1) | JP2801018B2 (enExample) |
| AT (2) | ATE133208T1 (enExample) |
| DE (2) | DE68929112T2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2031503A1 (en) * | 1989-05-31 | 1990-12-01 | Jyotsna Shah | Nucleic acid probes for the detection of chlamydia trachomatis |
| AU753971B2 (en) * | 1997-12-31 | 2002-10-31 | Millennium Pharmaceuticals, Inc. | Essential bacterial genes and their use |
| RU2160779C1 (ru) * | 1999-12-07 | 2000-12-20 | Горшков Олег Владимирович | Днк-зонд для типирования штаммов чумного микроба (bx-зонд) |
| RU2354700C2 (ru) * | 2006-05-26 | 2009-05-10 | Ооо "Научно-Производственная Фирма "Омикс" | Набор родо- и видоспецифичных олигонуклеотидных праймеров для детекции и видовой идентификации иерсиний методом мультиплексной полимеразной цепной реакции |
| JP5439892B2 (ja) | 2009-03-27 | 2014-03-12 | ヤマハ株式会社 | デジタル音響機器およびプログラム |
| US11939909B2 (en) | 2019-03-22 | 2024-03-26 | Honda Motor Co., Ltd. | Work machine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0155360B1 (en) * | 1981-09-25 | 1988-12-14 | John A. Webster, Jr. | Method for identifying and characterizing organisms |
-
1989
- 1989-03-17 AT AT89302637T patent/ATE133208T1/de not_active IP Right Cessation
- 1989-03-17 DE DE68929112T patent/DE68929112T2/de not_active Expired - Fee Related
- 1989-03-17 EP EP89302637A patent/EP0339783B1/en not_active Expired - Lifetime
- 1989-03-17 DE DE68925435T patent/DE68925435T2/de not_active Expired - Fee Related
- 1989-03-17 JP JP1065794A patent/JP2801018B2/ja not_active Expired - Fee Related
- 1989-03-17 AT AT94118668T patent/ATE187500T1/de not_active IP Right Cessation
- 1989-03-17 EP EP94118668A patent/EP0645460B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE68925435D1 (de) | 1996-02-29 |
| ATE133208T1 (de) | 1996-02-15 |
| EP0339783B1 (en) | 1996-01-17 |
| JP2801018B2 (ja) | 1998-09-21 |
| EP0339783A2 (en) | 1989-11-02 |
| EP0645460A3 (enExample) | 1995-04-19 |
| ATE187500T1 (de) | 1999-12-15 |
| EP0645460A2 (en) | 1995-03-29 |
| DE68929112D1 (de) | 2000-01-13 |
| EP0645460B1 (en) | 1999-12-08 |
| DE68925435T2 (de) | 1996-09-19 |
| EP0339783A3 (en) | 1991-10-23 |
| JPH029399A (ja) | 1990-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68921392T2 (de) | Proben zum spezifischen Nachweis von Escherichia coli und Shigella. | |
| DE68923665T2 (de) | Nachweis von Campylobacter. | |
| DE3851200T2 (de) | Nachweis von Listeria. | |
| DE60038015T2 (de) | Verfahren, basierend auf einer polynukleotidmatrix, zur identifizierung von mikroorganismen | |
| DE3486254T2 (de) | Verfahren zum aufspüren, identifizieren und quantifizieren von organismen und viren. | |
| DE3687232T3 (de) | Nachweis von Mikroben in einer Probe. | |
| DE3787299T2 (de) | Eine Zusammensetzung, spezifisch für Neisseria-Gonorrhoeae. | |
| DE69316801T2 (de) | Spezies-Spezifische Oligonukleotide gegen Bifidobakterien und Verfahren zum Nachweis unter Verwendung derselben | |
| DE69433201T2 (de) | Oligonukleotide und Verfahren zum Nachweis von Bakterien | |
| DE69427103T2 (de) | Verfahren, Reagenzien und Kits zur Untersuchung von Neisseria gonorrhoeae und Chlamydia trachomatis | |
| DE69230555T2 (de) | Oligonukleotiden komplementär zu mycobakterieller Nukleinsäure | |
| DE3785590T2 (de) | Campylobacter-sonde. | |
| DE69231961T2 (de) | Oligonucleotide zum Nachweis von Vibrio parahaemolyticus | |
| DE3688985T2 (de) | Verfahren und Sonde zum Nachweis von Actinobacillus Actinomycetemcomitans. | |
| DE69022167T2 (de) | Nukleinsäuresonden zum nachweis von staphylococcus aureus. | |
| DE69027910T2 (de) | Nukleinsäuresonden zum Nachweis von Chlamydia trachomatis und Chlamydia psittaci | |
| DE69425708T2 (de) | Nukleotidsequenzen die spezifisch mit einer nukleotidsequenz aus campylobacter jejuni hybridisieren | |
| EP0595167B1 (de) | Spezifische Gensonden und Verfahren zur Diagnostik von Candida albicans | |
| EP0408077B1 (de) | Neisseria gonorrhoeae-spezifische Oligonuleotid-Sonden | |
| DE68929112T2 (de) | Nachweis von Yersinia Intermedia | |
| DE69022362T2 (de) | Nukleinsäuresonden für die detektion von neisseria gonorrhoeae. | |
| DE69332202T2 (de) | Methoden zur diagnose von pilzinfektionen | |
| DE69318072T2 (de) | Genomische DNS-Fragmente von Streptococcus Pneumoniae, Hybridationssonden, Amplifikationsprimern und Verfahren für dessen Nachweis | |
| DE69230880T2 (de) | Nukleinsäure sonden welche bei nachweis von shigellabakterien verwendbar sind | |
| EP0574852A2 (de) | Spezifischer Nachweis von Neisseria Gonorrhoeae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |